Biogaia AB
STO:BIOG B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biogaia AB
STO:BIOG B
|
SE |
|
C
|
Canadian Imperial Bank of Commerce
NYSE:CM
|
CA |
Balance Sheet
Balance Sheet Decomposition
Biogaia AB
Biogaia AB
Balance Sheet
Biogaia AB
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
227
|
243
|
306
|
285
|
214
|
1 468
|
1 485
|
1 488
|
1 544
|
1 224
|
801
|
|
| Cash Equivalents |
227
|
243
|
306
|
285
|
214
|
1 468
|
1 485
|
1 488
|
1 544
|
1 224
|
801
|
|
| Short-Term Investments |
0
|
0
|
5
|
5
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
90
|
99
|
105
|
155
|
156
|
143
|
164
|
150
|
140
|
222
|
236
|
|
| Accounts Receivables |
75
|
92
|
97
|
142
|
130
|
102
|
128
|
131
|
106
|
190
|
217
|
|
| Other Receivables |
15
|
6
|
8
|
13
|
27
|
42
|
36
|
19
|
33
|
32
|
20
|
|
| Inventory |
44
|
40
|
33
|
44
|
68
|
72
|
103
|
143
|
181
|
153
|
167
|
|
| Other Current Assets |
5
|
3
|
6
|
6
|
9
|
6
|
0
|
16
|
9
|
11
|
15
|
|
| Total Current Assets |
365
|
385
|
454
|
494
|
452
|
1 690
|
1 752
|
1 797
|
1 874
|
1 610
|
1 219
|
|
| PP&E Net |
84
|
82
|
102
|
106
|
149
|
163
|
154
|
158
|
213
|
206
|
181
|
|
| PP&E Gross |
84
|
82
|
102
|
106
|
149
|
163
|
154
|
158
|
213
|
206
|
181
|
|
| Accumulated Depreciation |
40
|
46
|
53
|
61
|
70
|
93
|
122
|
144
|
166
|
189
|
212
|
|
| Intangible Assets |
16
|
0
|
0
|
46
|
53
|
50
|
48
|
46
|
46
|
1
|
1
|
|
| Goodwill |
0
|
0
|
0
|
5
|
5
|
5
|
149
|
172
|
165
|
175
|
146
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
8
|
11
|
10
|
0
|
0
|
0
|
22
|
26
|
28
|
28
|
28
|
|
| Other Long-Term Assets |
0
|
10
|
9
|
8
|
7
|
5
|
3
|
15
|
6
|
14
|
22
|
|
| Other Assets |
0
|
0
|
0
|
5
|
5
|
5
|
149
|
172
|
165
|
175
|
146
|
|
| Total Assets |
473
N/A
|
489
+3%
|
576
+18%
|
660
+15%
|
666
+1%
|
1 913
+187%
|
2 128
+11%
|
2 214
+4%
|
2 333
+5%
|
2 034
-13%
|
1 598
-21%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
24
|
17
|
21
|
34
|
28
|
48
|
42
|
32
|
49
|
48
|
57
|
|
| Accrued Liabilities |
32
|
25
|
41
|
57
|
54
|
49
|
56
|
78
|
86
|
101
|
105
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
8
|
8
|
0
|
11
|
9
|
7
|
7
|
|
| Other Current Liabilities |
22
|
31
|
50
|
54
|
35
|
30
|
28
|
44
|
51
|
49
|
31
|
|
| Total Current Liabilities |
77
|
73
|
111
|
145
|
125
|
135
|
127
|
165
|
196
|
206
|
199
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
17
|
21
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
1
|
7
|
10
|
11
|
14
|
13
|
15
|
5
|
5
|
|
| Minority Interest |
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
6
|
0
|
109
|
64
|
92
|
98
|
79
|
|
| Total Liabilities |
77
N/A
|
74
-5%
|
112
+52%
|
155
+38%
|
158
+2%
|
167
+6%
|
251
+50%
|
242
-4%
|
303
+25%
|
310
+2%
|
284
-9%
|
|
| Equity | ||||||||||||
| Common Stock |
17
|
17
|
17
|
17
|
17
|
20
|
20
|
20
|
20
|
20
|
20
|
|
| Retained Earnings |
357
|
378
|
403
|
444
|
469
|
577
|
703
|
798
|
857
|
530
|
120
|
|
| Additional Paid In Capital |
22
|
20
|
44
|
44
|
22
|
1 149
|
1 154
|
1 154
|
1 153
|
1 174
|
1 174
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 030
|
1 724
|
1 314
|
|
| Total Equity |
396
N/A
|
415
+5%
|
464
+12%
|
505
+9%
|
508
+1%
|
1 746
+244%
|
1 877
+8%
|
1 972
+5%
|
2 030
+3%
|
1 724
-15%
|
1 314
-24%
|
|
| Total Liabilities & Equity |
473
N/A
|
489
+3%
|
576
+18%
|
660
+15%
|
666
+1%
|
1 913
+187%
|
2 128
+11%
|
2 214
+4%
|
2 333
+5%
|
2 034
-13%
|
1 598
-21%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
17
|
84
|
84
|
84
|
84
|
98
|
98
|
101
|
101
|
101
|
101
|
|